Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

PLoS One · 2018 · PMC6226210 · PMID 30412630

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

borderline significanceP = 0.07so close (0.05 < p ≤ 0.1)

Coagulation biomarkers and VTE incidence In the total patient population, baseline TF was associated with VTE incidence with borderline significance (HR 2.8; P = 0.07).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.